therapeutic gain

therapeutic gain

Placebo-subtracted response Research The response in a treatment group minus the response in a control/placebo group. See Placebo effect.
Mentioned in ?
References in periodicals archive ?
Patients treated with fremanezumab had 3.1- to 3.8-day greater reductions in migraine days across dosing and migraine classification subgroups than patients receiving placebo, representing a therapeutic gain of 26 to 39 percentage points.
Title: Targeting regulatory T cells for therapeutic gain: Means and mechanisms
Their topics include bone morphogenetic protein, the structural biology and evolution of the TGF-beta family, TGF-beta family signaling in the control of cell proliferation and survival, bone morphogenetic proteins in vascular homeostasis and disease, and targeting TGF-beta signaling for therapeutic gain. ([umlaut] Ringgold, Inc., Portland, OR)
In subgroup analysis, we used the number needed to treat (NNT) to evaluate the usefulness of XFZYT plus TAMs for each subgroup with different AP subtypes; the NNT was calculated as 1/(Therapeutic Gain).
The investigators characterized the 10% therapeutic gain over placebo as "modest" and similar to that provided by other accepted therapies for IBS (Am.
The researchers characterized the 10% therapeutic gain over placebo as "modest" and similar to that provided by other accepted therapies for IBS (Am.
How could I advocate for one client's belief system to be used as a source of therapeutic gain while intentionally ignoring another's?
The lack of nursing awareness and education about biosimilars can lead to medication errors, adverse events or a delay in desired therapeutic gain for the patient.
Although the self-disclosure of a counselor could contribute to therapeutic gain, the technique may prove to be ineffective when counselors assume that their own experience matches or equates to that of the client (Egan, 2010; Ivey, Ivey, & Zalaquett, 2010).
"Resveratrol seems to have a therapeutic gain by making tumor cells more sensitive to radiation and making normal tissue less sensitive."
By targeting these patients, the biomarkers favorably alter the risk-benefit profile of pharmaceutical drugs, allowing non-responders to avoid potential side effects unbalanced by therapeutic gain. These biomarkers promise to eliminate much of the uncertainty involved in prescribing medications.
In 1992, Fujita, et al, reported in Cancer Research that vitamin C supplementation was shown to reduce the toxicity of conventional chemotherapeutic agents and to improve the therapeutic gain of radiation therapy.

Full browser ?